1. Home
  2. ALIT vs ZVRA Comparison

ALIT vs ZVRA Comparison

Compare ALIT & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alight Inc.

ALIT

Alight Inc.

HOLD

Current Price

$16.98

Market Cap

568.2M

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$9.51

Market Cap

562.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALIT
ZVRA
Founded
2017
2006
Country
United States
United States
Employees
N/A
61
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
568.2M
562.2M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
ALIT
ZVRA
Price
$16.98
$9.51
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$3.75
$23.00
AVG Volume (30 Days)
714.3K
1.5M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
21.33%
N/A
EPS Growth
N/A
159.21
EPS
N/A
0.60
Revenue
$2,262,000,000.00
$106,470,000.00
Revenue This Year
N/A
$37.27
Revenue Next Year
$0.14
$53.42
P/E Ratio
N/A
$16.05
Revenue Growth
N/A
350.91
52 Week Low
$0.48
$7.16
52 Week High
$23.68
$15.04

Technical Indicators

Market Signals
Indicator
ALIT
ZVRA
Relative Strength Index (RSI) 56.14 29.41
Support Level $1.12 $9.53
Resistance Level $23.68 $11.07
Average True Range (ATR) 1.71 0.57
MACD -0.90 -0.39
Stochastic Oscillator 2.91 10.87

Price Performance

Historical Comparison
ALIT
ZVRA

About ALIT Alight Inc.

Alight Inc is a technology-enabled services company delivering human capital management solutions to many complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth, and leave benefits) solutions, which currently operate under one reportable segment, Employer Solutions. The Employer Solutions segment is driven by the Alight Worklife platform, and includes integrated benefits administration, healthcare navigation, financial well-being, leave of absence management, and retiree healthcare. Geographically, the company generates the majority of its revenue from the United States.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: